Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,850.00p
   
  • Change Today:
    -30.00p
  • 52 Week High: 2,544.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 32,346
  • Market Cap: £1,221.61m
  • RiskGrade: 128

Genus suffers legal setback Stateside

By Alexander Bueso

Date: Friday 12 Aug 2016

LONDON (ShareCast) - (ShareCast News) - Genus suffered a legal setback Stateside as a US judge handed down a series of verdicts against the animal genetics specialist.
The US District Court for Wisconsin ruled that two of Genus rival ST´s patents were valid and had been infringed and that ABS, a unit of Genus, had materially broken its confidentiality obligations as set out in the 2012 semen sorting agreement between the two parties.

The rulings were linked to Genus´s ABS unit´s GSS technology for sexing bovine semen that does not subject the sperm cells to high pressures and forces.

UK-based Genus said it was still awaiting the judge´s decisión on a number of motions related to the provisions of the 2012 agreement and that it would update the market further when the rulings were made.

A verdict on the damages related to those matters would be considered by the jury later this week, Genus said in a statement.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 1,850.00p
Change Today -30.00p
% Change -1.60 %
52 Week High 2,544.00
52 Week Low 1,637.00
Volume 32,346
Shares Issued 66.03m
Market Cap £1,221.61m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.77% below the market average95.77% below the market average95.77% below the market average95.77% below the market average95.77% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
56.11% below the market average56.11% below the market average56.11% below the market average56.11% below the market average56.11% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
Income
85.12% below the market average85.12% below the market average85.12% below the market average85.12% below the market average85.12% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Growth
67.71% below the market average67.71% below the market average67.71% below the market average67.71% below the market average67.71% below the market average
64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Feb-24 09-Nov-23
Paid 28-Mar-24 08-Dec-23
Amount 10.30p 21.70p

Trades for 17-May-2024

Time Volume / Share Price
16:35 17,021 @ 1,850.00p
16:35 92 @ 1,850.00p
16:35 136 @ 1,850.00p
16:35 6 @ 1,850.00p
16:35 6 @ 1,850.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page